Fracture Prevention with Zoledronate in Older Women with Osteopenia

2018381 citationsJournal Articlebronze Open Access

Authors

Ian R. Reid · University of Auckland

Anne Horne · University of Auckland

Borislav Mihov · University of Auckland

Angela Stewart · University of Auckland

Elizabeth Garratt · University of Auckland

Sumwai Wong · University of Auckland

Katy R. Wiessing ·

Abstract

The risk of nonvertebral or vertebral fragility fractures was significantly lower in women with osteopenia who received zoledronate than in women who received placebo. (Funded by the Health Research Council of New Zealand; Australian New Zealand Clinical Trials Registry number, ACTRN12609000593235 .).

Topics & Keywords

Bone health and osteoporosis research Bone health and treatments Connective tissue disorders research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 379, Issue 25, pp. 2407-2416

DOI: 10.1056/nejmoa1808082

Field-Weighted Citation Impact: 37.11